FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

Based on the feedback received, this document may change. Learn about the consultation. Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible ...

This effect also happens with virtual nature, such as nature videos. A new study led by neuroscientists at the University of ...

Taking a common over-the-counter pain reliever could help keep certain ... "Aspirin, or other drugs that could target this pathway, have the potential to be less expensive than antibody-based ...

Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with chronic pain conditions, including peripheral neuropathy. You specialize in ...

Now hundreds of thousands of sick patients can’t find tests or drugs, and risk spreading the ... his frail shoulders hunched against the anticipation of pain. His trousers had become so loose ...

In 2022, the provincial government paid $70 million for five million bottles of children's acetaminophen and ibuprofin amid a domestic shortage of children's pain medication. About 30 per cent of ...